Screen and Filter UK Stocks by Fundamentals and Performance
Browse UK stocks using our free screener — filter by sector, market cap, P/E ratio, dividend yield, and more. Explore our global stock screener for all markets.
UK Stock Screener
| Symbol | Name | Price | Sector | Market Cap | P/E Ratio | Fwd P/E | Div Yield | Profit Margin | ROE | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
Solstad Offshore ASA | kr58.40 | - | kr12.59 Billion | - | 0.00 | 0.00% | 0.49% | 0.38% | kr290.00 Million |
|
|
Logitech International S.A. | £71.11 | - | £12.55 Billion | - | 0.00 | 0.03% | 0.15% | 0.32% | £4.77 Billion |
|
|
Biotage AB | kr141.85 | - | kr12.52 Billion | - | 0.00 | 0.01% | 0.13% | 0.07% | kr1.96 Billion |
|
|
FLSmidth & Co. | kr458.90 | - | kr12.49 Billion | - | 0.00 | 0.02% | - | 0.07% | kr14.61 Billion |
|
|
Sweco AB (publ) | kr133.15 | - | kr12.45 Billion | 0.24 | 0.00 | - | 0.07% | 0.19% | kr31.14 Billion |
|
|
Granges AB | kr138.45 | - | kr12.44 Billion | - | 0.00 | 0.04% | 0.04% | 0.10% | kr28.36 Billion |
|
|
Torm PLC Class A | kr166.50 | Energy | kr12.42 Billion | 2.24 | 11.31 | 0.05% | 0.47% | 0.56% | kr1.67 Billion |
|
|
Esperion Therapeutics, Inc. | $2.57 | - | $12.41 Billion | - | 0.00 | - | -0.35% | - | $303.80 Million |
|
|
Medifast Inc. | $10.03 | - | $12.40 Billion | 0.01 | 0.00 | - | -0.05% | -0.09% | $385.79 Million |
|
|
Scottish Mortgage Investment Trust plc | p1169.50 | Financial Services | p12.37 Billion | 3.72 | 0.00 | 0.00% | 0.97% | 0.28% | p3.76 Billion |
|
|
Swatch Group AG | £167.93 | - | £12.37 Billion | 0.17 | 0.00 | 0.02% | 0.00% | 0.00% | £6.28 Billion |
|
|
Amicorp FS (UK) PLC | $1.03 | Financial Services | $12.37 Billion | 1.03 | 0.00 | - | 0.11% | 0.22% | $16.30 Million |
|
|
bioMerieux S.A. | €91.18 | - | €12.30 Billion | - | 0.00 | 0.01% | 0.09% | 0.09% | €4.12 Billion |
|
|
Worldline | €0.34 | - | €12.30 Billion | - | 0.00 | - | -1.28% | -0.78% | €4.03 Billion |
|
|
Aker Solutions OL | kr42.93 | - | kr12.23 Billion | - | 0.00 | 0.14% | 0.04% | 0.23% | kr62.44 Billion |
|
|
Bavarian Nordic A/S | kr189.43 | - | kr12.22 Billion | - | 0.00 | - | 0.36% | 0.21% | kr6.89 Billion |
|
|
Carl Zeiss Meditec AG | €23.38 | - | €12.18 Billion | 0.46 | 0.00 | 0.00% | 0.05% | 0.06% | €2.20 Billion |
|
|
ChemoMetec A/S | kr396.60 | - | kr12.07 Billion | 1.09 | 0.00 | - | 0.36% | 0.28% | kr493.12 Million |
|
|
Porsche Automobil Holding SE | €31.39 | - | €12.05 Billion | - | 0.00 | 0.03% | - | -0.46% | - |
|
|
Norwegian Air Shuttle ASA | kr14.51 | - | kr12.04 Billion | - | 0.00 | 0.10% | 0.07% | 0.34% | kr37.40 Billion |
1041 - 1060 of 4484 stocks
Explore Stock Screeners by Country
- Argentina
- Australia
- Austria
- Belgium
- Botswana
- Brazil
- Canada
- Chile
- China
- Croatia
- Czech Republic
- Denmark
- Egypt
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Ireland
- Israel
- Kenya
- Korea
- Luxembourg
- Malawi
- Malaysia
- Mauritius
- Mexico
- Morocco
- Netherlands
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Rwanda
- Singapore
- South Africa
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- UK
- USA
- Uganda
- Unknown
- Vietnam
- Zambia
- Zimbabwe
About Stock Screening
Our UK stock screener provides comprehensive fundamental data and analytics to help you analyze UK-listed companies. Filter through stocks using multiple criteria and view detailed valuation and performance metrics.
- Fundamental Data: Access key metrics like P/E ratio, profit margin, ROE, and revenue
- Multiple Views: Switch between overview and performance views
- Advanced Filtering: Filter by exchange, country, sector, industry, market cap, and more
How to Use
Get started with our stock screener by following these simple steps:
- Filter Selection: Use the filters to narrow down stocks by exchange, country, sector, industry, or custom search
- View Options: Switch between overview and performance views to analyze different aspects
- Detailed Analysis: View comprehensive stock details including valuation, fundamentals, and performance data